Fixed versus flexible combination of GLP-1 receptor agonists with basal insulin in type 2 diabetes: A retrospective multicentre comparative effectiveness study.
Mario Luca MorieriMauro RigatoVera FrisonNatalino SimioniMichele D'AmbrosioFederica TadiottoAgostino PaccagnellaAnnunziata LapollaAngelo AvogaroGian Poalo FadiniPublished in: Diabetes, obesity & metabolism (2019)
In routine specialist care, initiation of the fixed or flexible BI/GLP-1RA combination allowed similar improvement in glycaemic control, but greater weight loss was observed with the flexible combination. This difference reflected dosages of BI and GLP-1RAs.
Keyphrases
- type diabetes
- weight loss
- palliative care
- glycemic control
- healthcare
- bariatric surgery
- cardiovascular disease
- rheumatoid arthritis
- solid state
- cross sectional
- randomized controlled trial
- quality improvement
- clinical practice
- gastric bypass
- study protocol
- pain management
- body mass index
- metabolic syndrome
- systemic lupus erythematosus
- obese patients
- health insurance
- affordable care act